StockGuru Alert: Profile Stock Medify Solutions Limited (OTC: MFYS) Up over 142%!!! MFYS went up over 142% today with over 6 Million Shares Traded which is 1663% above the 3 Month Average!!! Medify Solutions Limited (OTC: MFYS) View the StockGuru Profile for Medify Solutions: http://www.stockguru.com/profiles/mfys/ We Invite you to Visit the All New StockGuru Blog! Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks. Click HERE to visit the Blog, or go to: http://stockguru.com/blog/ StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $15,000 by a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
- 19 years ago
QualityStocks
StockGuru Trade Alert: Profile Stock Medify Solutions Limited (OTC: MFYS) Up over 142%
Related Post
-
QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Leveraging Positive Clinical Data to Shape Pivotal SGX942 Trial
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to…
-
QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Targets REE Bottlenecks with Scalable Solution
Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is positioned as the Trump administration is developing…
-
QualityStocksNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Achieves Key Milestone in Global Trial for Never-Smoker Lung Cancer
Lantern Pharma (NASDAQ: LTRN) is a clinical-stage biotechnology company leveraging artificial intelligence and machine learning…